Janux Therapeutics, Inc. (JANX) Form 8-K Material Events
Janux Therapeutics, Inc. (JANX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: JANX
CIK: 1817713
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerJudson Quiggle
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000919574-26-005493 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001274173-26-000200 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001193125-26-338078 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001193125-26-337977 | View SEC Doc Filr Page |
| 4 | 2026-07-31 | 2026-07-31 | 4 Filing | 0001864158-26-000006 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-28 | — | SCHEDULE 13G/A Filing | 0002012383-26-002544 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-08 | 4 Filing | 0001864158-26-000004 | View SEC Doc Filr Page |
| 8-K | 2026-06-23 | 2026-06-23 | 8-K | 0001193125-26-279428 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 Filing | 0001231919-26-000631 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 Filing | 0001863094-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 Filing | 0001666963-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 Filing | 0001780547-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 Filing | 0001202785-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 Filing | 0001248190-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 Filing | 0001326330-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-06-12 | 2026-06-11 | 8-K | 0001193125-26-269387 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-02 | 4 Filing | 0002069239-26-000005 | View SEC Doc Filr Page |
| 144 | 2026-06-02 | — | 144 Filing | 0002069239-26-000004 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001274173-26-000148 | View SEC Doc Filr Page |
| 4 | 2026-05-13 | 2026-05-11 | 4 Filing | 0002032671-26-000004 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-12 | — | SCHEDULE 13G Filing | 0000093751-26-000251 | View SEC Doc Filr Page |
| 10-Q | 2026-05-07 | 2026-03-31 | 10-Q | 0001193125-26-212146 | View SEC Doc Filr Page |
| 8-K | 2026-05-07 | 2026-05-07 | 8-K | 0001193125-26-211964 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-06 | — | SCHEDULE 13G/A Filing | 0000315066-26-001219 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-04-29 | — | SCHEDULE 13G Filing | 0000919574-26-002475 | View SEC Doc Filr Page |